The complexity of cell composition of the intima of large arteries: Focus on pericyte-like cells

Cardiovascular Research

Volumn 103, Issue 4, 2014, Pages 438-451

  Orekhov, Alexander N ^a   Bobryshev, Yuri V ^a,b   Chistiakov, Dimitry A ^c  

^a Skolkovo Innovation Center   (Russian Federation)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

Author keywords

Arteries; Atherogenesis; Atherosclerosis; Blood vessels; Intima; Pericyte like cells; Pericytes

Indexed keywords

CELL ANTIGEN; ANTIGEN;

ANTIGEN EXPRESSION; AORTA INTIMA; ARTERY INTIMA; ATHEROSCLEROSIS; CELL COMPOSITION; CELLULAR DISTRIBUTION; DIABETIC RETINOPATHY; ELECTRON MICROSCOPY; HEALTH CARE PLANNING; HUMAN; KIDNEY INJURY; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PERICYTE; PRIORITY JOURNAL; RENAL PERICYTE; RETINAL PERICYTE; REVIEW; SUBENDOTHELIUM; WOUND HEALING; ANGIOGENESIS; ANTIGEN SPECIFICITY; ARTERY CALCIFICATION; ARTERY THROMBOSIS; ATHEROSCLEROTIC PLAQUE; BASEMENT MEMBRANE; CELL ADHESION; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL MEMBRANE; CELL POPULATION; CYTOPLASM; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MESENCHYMAL STEM CELL; MYOFIBROBLAST; NEOVASCULARIZATION (PATHOLOGY); PERICYTE LIKE CELL; PERIPHERAL VASCULAR SYSTEM; PROTEIN EXPRESSION; VASA VASORUM; VASCULAR SMOOTH MUSCLE; ANIMAL; ARTERY; CYTOLOGY; INTIMA; PATHOLOGY; VASCULAR ENDOTHELIUM;

ANIMALS; ARTERIES; ATHEROSCLEROSIS; ENDOTHELIUM, VASCULAR; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES; TUNICA INTIMA;

EID: 84907327861     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu168     Document Type: Review

References (181)

1. Díaz-Flores L Jr. Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol Histopathol 2009;24: 909-969.
2. Dore-Duffy P, Cleary K. Morphology and properties of pericytes. Methods Mol Biol 2011;686: 49-68.
3. Armulik A, Genové G, Betsholtz C. Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell 2011;21: 193-215.
4. Capetandes A, Gerritsen ME. Simplified methods for consistent and selective culture of bovine retinal endothelial cells and pericytes. Invest Ophthalmol Vis Sci 1990;31: 1738-1744.
5. Ding Y, Song N, Luo Y. Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes. Cancer Microenviron 2012;5: 225-236.
6. Dulmovits BM, Herman IM. Microvascular remodeling and wound healing: a role for pericytes. Int J Biochem Cell Biol 2012;44: 1800-1812.
7. Montiel-Eulefi E, Nery AA, Rodrigues LC, Sánchez R, Romero F, Ulrich H. Neural differentiation of rat aorta pericyte cells. Cytometry A 2012;81: 65-71.
8. Faulkner JL, Szcykalski LM, Springer F, Barnes JL. Origin of interstitial fibroblasts in an accelerated model of angiotensin II-induced renal fibrosis. Am J Pathol 2005;167: 1193-1205.
9. Lin SL, Kisseleva T, Brenner DA, Duffield JS. Pericytes and perivascular fibroblasts are the primary source of collagen producing cells in obstructive fibrosis of the kidney. Am J Pathol 2008;173: 1617-1627.
10. Dulauroy S, Di Carlo SE, Langa F, Eberl G, Peduto L. Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nat Med 2012;18: 1262-1270.
11. Greenhalgh SN, Iredale JP, Henderson NC. Origins of fibrosis: pericytes take centre stage. F1000Prime Rep 2013;5: 37.
12. Schrimpf C, Duffield JS. Mechanisms of fibrosis: the role of the pericyte. Curr Opin Nephrol Hypertens 2011;20: 297-305.
13. Nicosia RF. The aortic ring model of angiogenesis: a quarter century of search and discovery. J Cell Mol Med 2009;13: 4113-4136.
14. Sarugaser R, Lickorish D, Baksh D, Hosseini MM, Davies JE. Human umbilical cord perivascular (HUCPV) cells: a source of mesenchymal progenitors. Stem Cells 2005;23: 220-229.
15. Campagnolo P, Cesselli D, Al Haj Zen A, Beltrami AP, Kränkel N, Katare R, Angelini G, Emanueli C, Madeddu P. Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential. Circulation 2010;121: 1735-1745.
16. Krushinsky AV, Orekhov AN, Smirnov VN. Stellate cells in the intima of human aorta. Application of alkaline dissociation method in the analysis of the vessel wall cellular content. Acta Anat (Basel) 1983;117: 266-269.
17. Orekhov AN, Karpova II, Tertov VV, Rudchenko SA, Andreeva ER, Krushinsky AV, Smirnov VN. Cellular composition of atherosclerotic and uninvolved human aortic subendothelial intima. Light-microscopic study of dissociated aortic cells. Am J Pathol 1984;115: 17-24.
18. Orekhov AN, Andreeva ER, Krushinsky AV, Novikov ID, Tertov VV, Nestaiko GV, Khashimov KhA, Repin VS, Smirnov VN. Intimal cells and atherosclerosis. Relationship between the number of intimal cells and major manifestations of atherosclerosis in the human aorta. Am J Pathol 1986;125: 402-415.
19. Rekhter MD, Andreeva ER, Mironov AA, Orekhov AN. Three-dimensional cytoarchitecture of normal and atherosclerotic intima of human aorta. Am J Pathol 1991;138: 569-580.
20. Rekhter MD, Andreeva ER, Andrianova IV, Mironov AA, OrekhovAN. Stellate cells of aortic intima: I. Human and rabbit. Tissue Cell 1992;24: 689-696.
21. Andreeva ER, Pugach IM, Gordon D, Orekhov AN. Continuous subendothelial network formed by pericyte-like cells in human vascular bed. Tissue Cell 1998;30: 127-135.
22. Kelly-Goss MR, Sweat RS, Stapor PC, Peirce SM, Murfee WL. Targeting pericytes for angiogenic therapies. Microcirculation 2013. doi: 10.1111/micc.12107.
23. Langhans TH. Beitrage zur normalen und pathologischen Anatomie der Arterien. Virchows Arch [A] 1866;36: 187-226.
24. Branwood AW. Modern Concepts of the Pathogenesis of Coronary Atherosclerosis. Edinburgh: Livingstone, 1963.
25. Geer JC. Fine structure of human aortic intimal thickening and fatty streaks. Lab Invest 1965;14: 1764-1783.
26. Geer JC, Haust MD. Smooth Muscle Cells in Atherosclerosis. Basel: Karger, 1972.
27. Jores L. Herz und Gefasse. In: Henke F, Lubarsch F (eds) Hand-buch der speziellen pathologischen Anatomie und Histologie. Berlin: Springer, 1924.
28. Anichkov NN. Special Pathologic Anatomy, Issue 2: Heart and Vessels, pt 2: Vessels, 262. Moscow: Medgiz, 1947.
29. Hansson GK, Jonasson L, Lojsthed B, Stemme S, Kocher O, Gabbiani G. Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques. Atherosclerosis 1988;72: 135-141.
30. Hansson GK, Holm J, Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol 1989;135: 169-175.
31. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999;340: 115-126.
32. Bylock AL, Gerrity RG. Visualization of monocyte recruitment into atherosclerotic arteries using fluorescent labelling. Atherosclerosis 1988;71: 17-25.
33. WisslerRW, Vesselinovitch D. Experimental models of human atherosclerosis. AnnNY Acad Sci 1968;149: 907-922.
34. Scott RF, Jones R, Daoud AS, Zumbo O, Coulston F, ThomasWA. Experimental atherosclerosis in rhesus monkeys. II. Cellular elements of proliferative lesions and possible role of cytoplasmic degeneration in pathogenesis as studied by electron microscopy. Exp Mol Pathol 1967;7: 34-57.
35. Altschul R. Selected studies on arteriosclerosis. Springfield: Thomas, 1950.
36. Schö nfelder M. Ortologie und Patologie der Langhans-Zellen der Aortenintima des Menschen. Pathol Microbiol (Basel) 1969;33: 129-145.
37. O'Neal RM. Derivation of intimal smooth muscle cells in normal arteries and atherosclerotic plaques. An overview. Prog Biochem Pharmacol 1977;13: 69-72.
38. Puchtler H, Sweat F, Terry MS, Conner HM. Investigation of staining, polarization and fluorescence-microscopic properties of myoendothelial cells. J Microsc 1969;89: 95-104.
39. Takebayashi S, Kubota I, Kamio A, Takagi T. Ultrastructural aspects of human atherosclerosis; role of the foam cells and modified smooth muscle cells. J Electron Microsc (Tokyo) 1972;21: 301-313.
40. ThomasWA, Florentin RA, NamSC, Kim DN, Jones RM, LeeKT. Preproliferative phase of atherosclerosis in swine fed cholesterol. Arch Pathol 1968;86: 621-643.
41. Ham AW, Cormack DH. Histology. Philadelphia: Lippincott, 1979.
42. Haust MD, More R, Movat HZ. The role of smooth muscle cells in the fibrogenesis of atherosclerosis. Am J Pathol 1960;37: 377-389.
43. Balis JU, Haust MD, More RH. Electron-microscopic studies in human atherosclerosis: cellular elements in aortic fatty streaks. Exp Mol Pathol 1964;90: 511-525.
44. Parker F, OdlandGF.Acorrelative histochemical, biochemical and electron microscopic study of experimental atherosclerosis in the rabbit aorta with special reference to the myo-intimal cell. Am J Pathol 1966;48: 197-239.
45. Chamley-Campbell JH, Campbell GR, Ross R. Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens. J Cell Biol 1981;89: 379-383.
46. Campbell GR, Chamley-Campbell JH. Smooth muscle phenotypic modulation: role in atherogenesis. Med Hypotheses 1981;7: 729-735.
47. Ross R, Wight TN, Strandness E, Thiele B. Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol 1984;114: 79-93.
48. Campbell GR, Campbell JH. Smooth muscle phenotypic changes in arterial wall homeostasis: implications for the pathogenesis of atherosclerosis. Exp Mol Pathol 1985;42: 139-162.
49. Campbell JH, Campbell GR, Kocher O, Gabbiani G. Cell biology of smooth muscle in culture: implications for atherogenesis. Int Angiol 1987;6: 73-79.
50. Campbell JH, Campbell GR. Smooth muscle phenotypic modulation-A personal experience. Arterioscler Thromb Vasc Biol 2012;32: 1784-1789.
51. Lacolley P, Regnault V, Nicoletti A, Li Z, Michel JB. The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. Cardiovasc Res 2012;95: 194-204.
52. Davies PF. Vascular cell interactions with special reference to the pathogenesis of atherosclerosis. Lab Invest 1986;55: 5-24.
53. Still WJ, O'Neal RM. Electron microscopic study of experimental atherosclerosis in the rat. Am J Pathol 1962;40: 21-35.
54. Ham AW. Histology. Philadelphia: Lippincott, 1974.
55. Kutcher ME, Herman IM. The pericyte: cellular regulator of microvascular blood flow. Microvasc Res 2009;77: 235-246.
56. Díaz-Flores L, Gutiérrez R, Varela H, Rancel N, Valladares F. Microvascular pericytes: a review of their morphological and functional characteristics. Histol Histopathol 1991;6: 269-286.
57. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001;7: 211-228.
58. Torsney E, Xu Q. Resident vascular progenitor cells. J Mol Cell Cardiol 2011;50: 304-311.
59. Gonzalez-Crussi F, Reyes-Mugica M. Cellular hemangiomas ('hemangioendotheliomas') in infants. Light microscopic, immunohistochemical, and ultrastructural observations. Am J Surg Pathol 1991;15: 769-778.
60. Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: candidate MSC-like cells from umbilical cord. Stem Cells 2003;21: 105-110.
61. Vanderlaan PA, Reardon CA. Thematic review series: the immune system and atherogenesis. The unusual suspects: an overview of the minor leukocyte populations in atherosclerosis. J Lipid Res 2005;46: 829-838.
62. Zengin E, Chalajour F, Gehling UM, Ito WD, Treede H, Lauke H, Weil J, Reichenspurner H, Kilic N, Ergun S. Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development 2006; 133: 1543-1551.
63. Ergün S, Tilki D, Klein D. Vascular wall as a reservoir for different types of stem and progenitor cells. Antioxid Redox Signal 2011;15: 981-995.
64. Tintut Y, Alfonso Z, Saini T, Radcliff K, Watson K, Boström K, Demer LL. Multilineage potential of cells from the artery wall. Circulation 2003;108: 2505-2510.
65. Glukhova MA, Kabakov AE, Frid MG, Ornatsky OI, Belkin AM, Mukhin DN, Orekhov AN, Koteliansky VE, Smirnov VN. Modulation of human aorta smooth muscle cell phenotype: a study of muscle-specific variants of vinculin, caldesmon, and actin expression. Proc Natl Acad Sci USA 1988;85: 9542-9546.
66. Andreeva ER, Pugach IM, Orekhov AN. Subendothelial smooth muscle cells of human aorta express macrophage antigen in situ and in vitro. Atherosclerosis 1997;135: 19-27.
67. Greaves DR, Gordon S. Macrophage-specific gene expression: current paradigms and future challenges. Int J Hematol 2002;76: 6-15.
68. Song L, Lee C, Schindler C. Deletion of the murine scavenger receptor CD68. J Lipid Res 2011;52: 1542-1550.
69. Kunz-Schughart LA, Weber A, Rehli M, Gottfried E, Brockhoff G, Krause SW, Andreesen R, Kreutz M. The 'classical' macrophage markerCD68 is strongly expressed in primary human fibroblasts. Verh Dtsch Ges Pathol 2003;87: 215-223.
70. Beranek JT. CD68 is not a macrophage-specific antigen. Ann Rheum Dis 2005;64: 342-343.
71. Boström K, Watson KE, Horn S, Wortham C, Herman IM, Demer LL. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1993;91: 1800-1809.
72. Nayak RC, Berman AB, George KL, Eisenbarth GS, King GL. A monoclonal antibody (3G5)-defined ganglioside antigen is expressed on the cell surface of microvascular pericytes. J Exp Med 1988;167: 1003-1015.
73. Moreno PR, Purushothaman M, Purushothaman KR. Plaque neovascularization: defense mechanisms, betrayal, or a war in progress. Ann N Y Acad Sci 2012;1254: 7-17.
74. Andreeva ER, Rekhter MD, Romanov YuA, Antonova GM, Antonov AS, Mironov AA, Orekhov AN. Stellate cells of aortic intima: II. Arborization of intimal cells in culture. Tissue Cell 1992;24: 697-704.
75. Schlingemann RO, Rietveld FJ, deWaal RM, Ferrone S, Ruiter DJ. Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds. Am J Pathol 1990;136: 1393-1405.
76. Andreeva ER, Orekhov AN, Smirnov VN. Quantitative estimation of lipid-laden cells in atherosclerotic lesions of the human aorta. Acta Anat 1991;141: 316-323.
77. Bobryshev YV, Lord RS. Langhans cells of human arterial intima: uniform by stellate appearance but different by nature. Tissue Cell 1996;28: 177-194.
78. Andreeva ER, Serebryakov VN, Orekhov AN. Gap junctional communication in primary culture of cells derived fromhuman aortic intima. Tissue Cell 1995;27: 591-597.
79. Bobryshev YV, Lord RS. Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of vascular dendritic cells in athero-resistant and athero-prone areas of the normal aorta. Arch Histol Cytol 1995; 58: 307-322.
80. BobryshevYV. Dendritic cells and their involvement in atherosclerosis. Curr Opin Lipidol 2000;11: 511-517.
81. Millonig G, Niederegger H, RablW, Hochleitner BW, Hoefer D, Romani N, Wick G. Network of vascular-associated dendritic cells in intima of healthy young individuals. Arterioscler Thromb Vasc Biol 2001;21: 503-508.
82. Bobryshev YV, Moisenovich MM, Pustovalova OL, Agapov II, Orekhov AN. Widespread distribution of HLA-DR-expressing cells in macroscopically undiseased intima of the human aorta: a possible role in surveillance and maintenance of vascular homeostasis. Immunobiology 2012;217: 558-568.
83. Bobryshev YV, Andreeva ER, Mikhailova IA, Andrianova IV, Moisenovich MM, Khapchaev S, Agapov II, Sobenin IA, Lusta KA, Orekhov AN. Correlation between lipid deposition, immune-inflammatory cell content and MHC class II expression in diffuse intimal thickening of the human aorta. Atherosclerosis 2011;219: 171-183.
84. Antonelli-Orlidge A, Saunders KB, Smith SR, D'Amore PA. An activated form of transforming growth factor b is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci USA 1989;86: 4544-4548.
85. Kutcher ME, Kolyada AY, Surks HK, Herman IM. Pericyte Rho GTPase mediates both pericyte contractile phenotype and capillary endothelial growth state. Am J Pathol 2007; 171: 693-701.
86. van Nieuw Amerongen GP, Koolwijk P, Versteilen A, van HinsberghVW. Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro. Arterioscler Thromb Vasc Biol 2003;23: 211-217.
87. Bagley RG, Weber W, Rouleau C, Teicher BA. Pericytes and endothelial precursor cells: cellular interactions and contributions to malignancy. Cancer Res 2005;65: 9741-9750.
88. Balabanov R, Washington R, Wagnerova J, Dore-Duffy P. CNS microvascular pericytes express macrophage-like function, cell surface integrin aM and macrophage marker ED-2. Microvasc Res 1996;52: 127-142.
89. Thomas WE. Brain macrophages: on the role of pericytes and perivascular cells. Brain Res Brain Res Rev 1999;31: 42-57.
90. Tó th P, Lázár G. Brain phagocytes may empty tissue debris into capillaries. J Neurocytol 2001;30: 717-726.
91. Tigges U, Hyer EG, Scharf J, Stallcup WB. FGF2-dependent neovascularization of subcutaneous Matrigel plugs is initiated by bone marrow-derived pericytes and macrophages. Development 2008;135: 523-532.
92. Graumann U, Ritz MF, Rivero BG, Hausmann O. CD133 expressing pericytes and relationship to SDF-1 and CXCR4 in spinal cord injury. Curr Neurovasc Res 2010;7: 144-154.
93. Balabanov R, Beaumont T, Dore-Duffy P. Role of central nervous system microvascular pericytes in activation of antigen-primed splenic T-lymphocytes. J Neurosci Res 1999;55: 578-587.
94. Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen 2008;16: 585-601.
95. Li B, Wang JH. Fibroblasts and myofibroblasts in wound healing: force generation and measurement. J Tissue Viability 2011;20: 108-120.
96. Pan SY, Chang YT, Lin SL. Microvascular pericytes in healthy and diseased kidneys. Int J Nephrol Renovasc Dis 2014;7: 39-48.
97. Fetting JL, Guay JA, Karolak MJ, Iozzo RV, Adams DC, Maridas DE, Brown AC, Oxburgh L. FOXD1 promotes nephron progenitor differentiation by repressing decorin in the embryonic kidney. Development 2014;141: 17-27.
98. Humphreys BD, Lin SL, Kobayashi A, Hudson TE, Nowlin BT, Bonventre JV, ValeriusMT, McMahon AP, Duffield JS. Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 2010;176: 85-97.
99. Asada N, Takase M, Nakamura J, Oguchi A, Asada M, Suzuki N, Yamamura K, Nagoshi N, Shibata S, Rao TN, Fehling HJ, Fukatsu A, Minegishi N, Kita T, Kimura T, Okano H, Yamamoto M, Yanagita M. Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice. J Clin Invest 2011;121: 3981-3990.
100. Rojas A, Chang FC, Lin SL, Duffield JS. The role played by perivascular cells in kidney interstitial injury. Clin Nephrol 2012;77: 400-408.
101. Kida Y, Duffield JS. Pivotal role of pericytes in kidney fibrosis. Clin Exp Pharmacol Physiol 2011;38: 467-473.
102. LeBleu VS, Taduri G, O'Connell J, Teng Y, Cooke VG, Woda C, Sugimoto H, Kalluri R. Origin and function of myofibroblasts in kidney fibrosis. Nat Med 2013;19: 1047-1053.
103. Schrimpf C, Xin C, Campanholle G, Gill SE, Stallcup W, Lin SL, Davis GE, Gharib SA, Humphreys BD, Duffield JS. Pericyte TIMP3 andADAMTS1 modulate vascular stability after kidney injury. J Am Soc Nephrol 2012;23: 868-883.
104. Wang HU, Chen ZF, Anderson DJ. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 1998;93: 741-753.
105. Kida Y, Ieronimakis N, Schrimpf C, Reyes M, Duffield JS. EphrinB2 reverse signaling protects against capillary rarefaction and fibrosis after kidney injury. J Am Soc Nephrol 2013; 24: 559-572.
106. Hakroush S, Moeller MJ, Theilig F, Kaissling B, Sijmonsma TP, Jugold M, Akeson AL, Traykova-Brauch M, Hosser H, Hähnel B, Gröne HJ, Koesters R, Kriz W. Effects of increased renal tubular vascular endothelial growth factor (VEGF) on fibrosis, cyst formation, and glomerular disease. Am J Pathol 2009;175: 1883-1895.
107. Chen YT, Chang FC, WuCF, Chou YH, Hsu HL, ChiangWC, Shen J, Chen YM, WuKD, Tsai TJ, Duffield JS, Lin SL. Platelet-derived growth factor receptor signaling activates pericyte-myofibroblast transition in obstructive and post-ischemic kidney fibrosis. Kidney Int 2011;80: 1170-1181.
108. Choi YJ, Chakraborty S, Nguyen V, Nguyen C, Kim BK, Shim SI, Suki WN, Truong LD. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: altered expression of vascular endothelial growth factor. Hum Pathol 2000; 31: 1491-1497.
109. Ohashi R, Shimizu A, Masuda Y, Kitamura H, Ishizaki M, Sugisaki Y, Yamanaka N. Peritubular capillary regression during the progression of experimental obstructive nephropathy. J Am Soc Nephrol 2002;13: 1795-1805.
110. Kretzschmar M, Massagué J. SMADs: mediators and regulators of TGF-beta signaling. Curr Opin Genet Dev 1998;8: 103-111.
111. Fukuda K, Yoshitomi K, Yanagida T, Tokumoto M, Hirakata H. Quantification of TGF-beta1 mRNA along rat nephron in obstructive nephropathy. Am J Physiol Renal Physiol 2001;281: F513-F521.
112. Miao CG, YangYY, He X, Huang C, Huang Y, Zhang L, LvXW, Jin Y, Li J.Wnt signaling in liver fibrosis: progress, challenges and potential directions. Biochimie 2013;95: 2326-2335.
113. Cisternas P, Henriquez JP, Brandan E, Inestrosa NC. Wnt signaling in skeletal muscle dynamics: myogenesis, neuromuscular synapse and fibrosis. Mol Neurobiol 2014;49: 574-589.
114. DiRocco DP, Kobayashi A, Taketo MM, McMahon AP, Humphreys BD. Wnt4/ b-catenin signaling in medullary kidney myofibroblasts. J Am Soc Nephrol 2013;24: 1399-1412.
115. Ren S, Johnson BG, Kida Y, Ip C, Davidson KC, Lin SL, Kobayashi A, Lang RA, Hadjantonakis AK, Moon RT, Duffield JS. LRP-6 is a coreceptor for multiple fibrogenic signaling pathways in pericytes and myofibroblasts that are inhibited byDKK-1. Proc Natl Acad Sci USA 2013;110: 1440-1445.
116. Charney DI, Walton DF, Cheung AK. Atherosclerosis in chronic renal failure. Curr Opin Nephrol Hypertens 1993;2: 876-882.
117. Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, Salem DN, Levey AS, Sarnak MJ. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 2004;15: 1307-1315.
118. Napoli C, Casamassimi A, Crudele V, Infante T, Abbondanza C. Kidney and heart interactions during cardiorenal syndrome: a molecular and clinical pathogenic framework. Future Cardiol 2011;7: 485-497.
119. Ronco C, Ronco F. Cardio-renal syndromes: a systematic approach for consensus definition and classification. Heart Fail Rev 2012;17: 151-160.
120. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001;38: 938-942.
121. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int 2006;69: 213-217.
122. Leake DS. Does an acidic pH explain why low density lipoprotein is oxidised in atherosclerotic lesions? Atherosclerosis 1997;129: 149-157.
123. Tovar AM, Pecly IM, Rangel EP, Melo-Filho NM, Mourão PA, LeiteMJr. Experimentally induced metabolic acidosis in rabbits modulates the interaction of aortic glycosaminoglycan with plasma low-density lipoprotein-an interesting observation about the association of acidosis and atherosclerosis. Atherosclerosis 2007;192: 33-39.
124. Disthabanchong S. Vascular calcification in chronic kidney disease: pathogenesis and clinical implication. World J Nephrol 2012;1: 43-53.
125. Bro S. Cardiovascular effects of uremia in apolipoprotein E-deficient mice. Dan MedBull 2009;56: 177-192.
126. Ito S, Yoshida M. Protein-bound uremic toxins: new culprits of cardiovascular events in chronic kidney disease patients. Toxins (Basel) 2014;6: 665-678.
127. Silverberg DS, Wexler D, Iaina A, Schwartz D. The interaction between heart failure and other heart diseases, renal failure, and anemia. Semin Nephrol 2006;26: 296-306.
128. Sivaprasad S, Gupta B, Crosby-Nwaobi R, Evans J. Prevalence of diabetic retinopathy in various ethnic groups: a worldwide perspective. Surv Ophthalmol 2012;57: 347-370.
129. Sims DE. Diversity within pericytes. Clin Exp Pharmacol Physiol 2000;27: 842-846.
130. Ferreiro JL, Gómez-Hospital JA, Angiolillo DJ. Platelet abnormalities in diabetes mellitus. Diab Vasc Dis Res 2010;7: 251-259.
131. Ishibashi T. Cell biology of intraocular vascular diseases. Jpn J Ophthalmol 2000;44: 323-324.
132. Campochiaro PA. Ocular neovascularization. J Mol Med (Berl) 2013;91: 311-321.
133. Beltramo E, Porta M. Pericyte loss in diabetic retinopathy: mechanisms and consequences. Curr Med Chem 2013;20: 3218-3225.
134. Enge M, Bjarnegård M, Gerhardt H, Gustafsson E, Kalén M, Asker N, Hammes HP, Shani M, Fässler R, Betsholtz C. Endothelium-specific platelet-derived growth factor-B ablation mimics diabetic retinopathy. EMBO J 2002;21: 4307-4316.
135. Feenstra DJ, Yego EC, Mohr S. Modes of retinal cell death in diabetic retinopathy. J Clin Exp Ophthalmol 2013;4: 298.
136. Geraldes P, Hiraoka-Yamamoto J, Matsumoto M, Clermont A, Leitges M, Marette A, Aiello LP, Kern TS, King GL. Activation of PKC-delta and SHP-1 by hyperglycemia causes vascular cell apoptosis and diabetic retinopathy. Nat Med 2009;15: 1298-1306.
137. Fu D, WuM, Zhang J, Du M, Yang S, Hammad SM, Wilson K, Chen J, Lyons TJ. Mechanisms of modified LDL-induced pericyte loss and retinal injury in diabetic retinopathy. Diabetologia 2012;55: 3128-3140.
138. Tu Z, Li Y, Smith DS, Sheibani N, Huang S, Kern T, Lin F. Retinal pericytes inhibit activated T cell proliferation. Invest Ophthalmol Vis Sci 2011;52: 9005-9010.
139. Motiejunaite R, Kazlauskas A. Pericytes and ocular diseases. Exp Eye Res 2008;86: 171-177.
140. Gariano RF, Gardner TW. Retinal angiogenesis in development and disease. Nature 2005;438: 960-966.
141. Carmeliet P. Angiogenesis in life, disease and medicine. Nature 2005;438: 93-936.
142. Ribatti D, Nico B, Crivellato E, Vacca A. The structure of the vascular network of tumors. Cancer Lett 2007;248: 18-23.
143. Ribatti D, Nico B, Crivellato E. The role of pericytes in angiogenesis. Int J Dev Biol 2011; 55: 261-268.
144. Eberhard A, Kahlert S, GoedeV, Hemmerlein B, Plate KH, Augustin HG. Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies. Cancer Res 2000;60: 1388-1393.
145. Baluk P, Morikawa S, Haskell A, Mancuso M, McDonaldDM.Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors. Am J Pathol 2003;163: 1801-1815.
146. Morikawa S, Baluk P, KaidohT, Haskell A, Jain RK, McDonaldDM. Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol 2002;160: 985-1000.
147. Simonavicius N, Robertson D, Bax DA, Jones C, Huijbers IJ, Isacke CM. Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma. Mod Pathol 2008;21: 308-315.
148. Cheng L, Huang Z, Zhou W, Wu Q, Donnola S, Liu JK, Fang X, Sloan AE, Mao Y, Lathia JD, MinW, McLendon RE, Rich JN, Bao S. Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth. Cell 2013;153: 139-152.
149. Abramsson A, Lindblom P, Betsholtz C. Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J Clin Invest 2003;112: 1142-1151.
150. GuoP, HuB, GuW, Xu L, Wang D, Huang HJ, Cavenee WK, Cheng SY. Platelet-derived growth factor-B enhances glioma angiogenesis by stimulating vascular endothelial growth factor expression in tumor endothelia and by promoting pericyte recruitment. Am J Pathol 2003;162: 1083-1093.
151. Nissen LJ, Cao R, Hedlund EM, Wang Z, Zhao X, Wetterskog D, Funa K, Bråkenhielm E, Cao Y. Angiogenic factors FGF2 and PDGF-BB synergistically promote murine tumor neovascularization and metastasis. J Clin Invest 2007;117: 2766-2777.
152. Armulik A, Abramsson A, Betsholtz C. Endothelial/pericyte interactions. Circ Res 2005; 97: 512-523.
153. Fagiani E, LorentzP, Kopfstein L, Christofori G. Angiopoietin-1 and -2 exert antagonistic functions in tumor angiogenesis, yet both induce lymphangiogenesis. Cancer Res 2011; 71: 5717-5727.
154. Xue Y, Cao R, Nilsson D, Chen S, Westergren R, Hedlund EM, Martijn C, Rondahl L, Krauli P, Walum E, Enerbäck S, Cao Y. FOXC2 controls Ang-2 expression and modulates angiogenesis, vascular patterning, remodeling, and functions in adipose tissue. Proc Natl Acad Sci USA 2008;105: 10167-10172.
155. DuW, Takuwa N, Yoshioka K, Okamoto Y, Gonda K, Sugihara K, Fukamizu A, Asano M, Takuwa Y. S1P(2), theGprotein-coupled receptor for sphingosine-1- phosphate, negatively regulates tumor angiogenesis and tumor growth in vivo in mice. Cancer Res 2010; 70: 772-781.
156. Chantrain CF, Henriet P, Jodele S, Emonard H, Feron O, Courtoy PJ, DeClerck YA, Marbaix E. Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases. Eur J Cancer 2006;42: 310-318.
157. Ahmed F, Steele JC, Herbert JM, Steven NM, Bicknell R. Tumor stroma as a target in cancer. Curr Cancer Drug Targets 2008;8: 447-453.
158. Erber R, Thurnher A, Katsen AD, Groth G, Kerger H, Hammes HP, Menger MD, Ullrich A, Vajkoczy P. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms. FASEB J 2004;18: 338-340.
159. CaoR, XueY, Hedlund EM, Zhong Z, Tritsaris K, Tondelli B, Lucchini F, Zhu Z, Dissing S, Cao Y. VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy. Proc Natl Acad Sci USA 2010;107: 856-861.
160. Lu C, Thaker PH, Lin YG, Spannuth W, Landen CN, Merritt WM, Jennings NB, Langley RR, Gershenson DM, Yancopoulos GD, Ellis LM, Jaffe RB, Coleman RL, Sood AK. Impact of vessel maturation on antiangiogenic therapy in ovarian cancer. Am J Obstet Gynecol 2008;198: 477.e1-477.e10.
161. Eriksson A, Cao R, Pawliuk R, Berg SM, Tsang M, Zhou D, Fleet C, Tritsaris K, Dissing S, Leboulch P, Cao Y. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers. Cancer Cell 2002;1: 99-108.
162. Zhang J, CaoR, ZhangY, JiaT, CaoY, Wahlberg E. Differential roles ofPDGFR-alpha and PDGFR-beta in angiogenesis and vessel stability. FASEB J 2009;23: 153-163.
163. Ruan J, Luo M, Wang C, Fan L, Yang SN, Cardenas M, Geng H, Leonard JP, Melnick A, Cerchietti L, Hajjar KA. Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes. Blood 2013;121: 5192-5202.
164. Hasumi Y, Klosowska-Wardega A, Furuhashi M, Ostman A, Heldin CH, Hellberg C. Identification of a subset of pericytes that respond to combination therapy targeting PDGF and VEGF signaling. Int J Cancer 2007;121: 2606-2614.
165. Hosaka K, Yang Y, Seki T, Nakamura M, Andersson P, Rouhi P, Yang X, Jensen L, Lim S, Feng N, Xue Y, Li X, Larsson O, Ohhashi T, Cao Y. Tumour PDGF-BB expression levels determine dual effects of anti-PDGF drugs on vascular remodelling and metastasis. Nat Commun 2013;4: 2129.
166. Korpisalo P, Karvinen H, Rissanen TT, Kilpijoki J, Marjomäki V, Baluk P, McDonald DM, Cao Y, Eriksson U, Alitalo K, Ylä-Herttuala S. Vascular endothelial growth factor-A and platelet-derived growth factor-Bcombination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogenic vessels. Circ Res 2008;103: 1092-1099.
167. Orekhov AN, Andreeva ER, Mikhailova IA, Gordon D. Cell proliferation in normal and atherosclerotic human aorta: proliferative splash in lipid-rich lesions. Atherosclerosis 1998;139: 41-48.
168. Orekhov AN, Andreeva ER, Andrianova IV, BobryshevYV. Peculiarities of cell composition and cell proliferation in different type atherosclerotic lesions in carotid and coronary arteries. Atherosclerosis 2010;212: 436-443.
169. Ivanov D, Philippova M, Antropova J, Gubaeva F, Iljinskaya O, Tararak E, Bochkov V, Erne P, Resink T, Tkachuk V. Expression of cell adhesion molecule T-cadherin in the human vasculature. Histochem Cell Biol 2001;115: 231-242.
170. Takeuchi T, Ohtsuki Y. Recent progress in T-cadherin (CDH13, H-cadherin) research. Histol Histopathol 2002;16: 1287-1293.
171. Liu Y, Wilkinson FL, Kirton JP, Jeziorska M, Iizasa H, Sai Y, Nakashima E, Heagerty AM, Canfield AE, Alexander MY. Hepatocyte growth factor and c-Met expression in pericytes: implications for atherosclerotic plaque development. J Pathol 2007;212: 12-19.
172. LoganCW, Nusse R. The Wnt signaling pathway in development and disease. Cell Dev Biol 2004;20: 781-810.
173. Kirton JP, Crofts NJ, George SJ, Brennan K, Canfield AE. Wnt/beta-catenin signaling stimulates chondrogenic and inhibits adipogenic differentiation of pericytes: potential relevance to vascular disease? Circ Res 2007;101: 581-589.
174. Farrington-Rock C, Crofts NJ, Doherty MJ, Ashton BA, Griffin-Jones C, Canfield AE. Chondrogenic and adipogenic potential of microvascular pericytes. Circulation 2004; 110: 2226-2232.
175. Bobik A, Agrotis A, Kanellakis P, Dilley R, Krushinsky A, Smirnov V, Tararak E, Condron M, Kostolias G. Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development. Circulation 1999;99: 2883-2891.
176. Shao JS, Cai J, Towler DA. Molecular mechanisms of vascular calcification: lessons learned from the aorta. Arterioscler Thromb Vasc Biol 2006;26: 1423-1430.
177. BrightonCT, LorichDG, Kupcha R, ReillyTM, Jones AR, Woodbury RA. The pericyte as a possible osteoblast progenitor cell. Clin Orthopaed Rel Res 1992;275: 287-299.
178. Díaz-Flores L, Gutiérrez R, Madrid JF, Varela H, Valladares F, Acosta E, Martín-Vasallo P, Doherty MJ, Ashton BA, Walsh S, Beresford JN, Grant ME, Canfield AE. Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res 1998;13: 828-838.
179. Wilkinson FL, Liu Y, Rucka AK, Jeziorska M, Hoyland JA, Heagerty AM, Canfield AE, Alexander MY. Contribution of VCAF-positive cells to neovascularization and calcification in atherosclerotic plaque development. J Pathol 2007;211: 362-369.
180. Colett GD, Canfield AE. Angiogenesis and pericytes in the initiation of ectopic calcification. Circ Res 2005;96: 930-938.
181. Juchem G, Weiss DR, Gansera B, Kemkes BM, Mueller-Hoecker J, Nees S. Pericytes in the macrovascular intima: possible physiological and pathogenetic impact. Am J Physiol Heart Circ Physiol 2010;298: H754-H770.